RESUMO
In the present study, a range of sustainable, biocompatible and biodegradable polyurethanes (PU-1 to PU-4) were synthesized using different combinations of biobased polyol (obtained through the epoxidation of soybean oil, followed by ring opening with ethanol) and polyethylene glycol (PEG) and isophorone diisocyanate. The sustainable chain extender used in this study was synthesized by the esterification of lactic acid with ethylene glycol (EG). The synthesized PU samples were characterized through scanning electron microscopy (SEM), Fourier transformed infrared (FTIR) and nuclear magnetic resonance (1H NMR and 13C NMR) spectroscopy. Wetting ability and thermal degradation analysis (TGA) of the samples were also studied. Subsequently, these PUs were examined as potential drug delivery systems using Gabapentin as a model drug, which was loaded in the polymer matrix using the solvent evaporation method. The drug release studies were carried out in 0.06 N HCl as a release medium according to the method outlined in the United States Pharmacopeia. The maximum drug release was observed for sample PU-P1, which was found to be 53.0 % after 6 h. Moreover, a comparison of different PU samples revealed a trend wherein the values of drug release were decreased with an increase in the PEG content.
Assuntos
Poliuretanos , Óleo de Soja , Poliuretanos/química , Ácido Láctico , Sistemas de Liberação de Medicamentos , Fenômenos Químicos , Polietilenoglicóis/químicaRESUMO
In this research work, the crosslinked structure of polyurethane has been exploited for sustained drug delivery. Polyurethane composites have been prepared by the reaction of isophorone diisocyanate (IPDI) and polycaprolactone diol (PCL), which were further extended by varying the mole ratios of amylopectin (AMP) and 1,4-butane diol (1,4-BDO) chain extenders. The progress and completion of the reaction of polyurethane (PU) were confirmed using Fourier Transform infrared (FTIR) and nuclear magnetic resonance (1H NMR) spectroscopic techniques. Gel permeation chromatography (GPC) analysis showed that the molecular weights of prepared polymers were increased with the addition of amylopectin into the PU matrix. The molecular weight of AS-4 (Mw ≈ 99,367) was found threefold as compared to amylopectin-free PU (Mw ≈ 37,968). Thermal degradation analysis was done using thermal gravimetric analysis (TGA) and inferred that AS-5 showed stability up to 600 °C which was the maximum among all PUs because AMP has a large number of -OH units for linking with prepolymer resulting in a more cross-linked structure which improved the thermal stability of the AS-5 sample. The samples prepared with AMP showed less drug release (<53 %) as compared to the PU sample prepared without AMP (AS-1).
Assuntos
Polímeros , Poliuretanos , Poliuretanos/química , Preparações Farmacêuticas , Liberação Controlada de Fármacos , Polímeros/química , Espectroscopia de Ressonância MagnéticaRESUMO
Waxy corn starch modified polyurethane elastomers were synthesized by step growth polymerization reaction between NCO-terminated prepolymer and chain extenders (1,4-butanediol/starch). Isophorone diisocyanates (IPDI) was reacted with hydroxyl terminated polybutadiene (HTPB) to synthesize prepolymer that was reacted with different moles of 1,4-butanediol (1,4-BDO) and starch to produced five samples of polyurethane. These specimens were analyzed by Fourier transformed infrared (FTIR) and proton Nuclear Magnetic Resonance (1H NMR) spectroscopy to determine the structural information. However, role of starch as chain extender was examined by gel permeation chromatography (GPC). Additionally, starch increased the thermal stability of PUs as compared to the conventional chain extender (1,4-BDO). Over all, this work has been designed to develop biodegradable polyurethanes that could be used in biomedical systems.